Dexamethasone treatment in the newborn rat: Fatty acid profiling of lung, brain, and serum lipids

Journal of Applied Physiology

Volumn 98, Issue 3, 2005, Pages 981-990

  Bruder, Eric D ^a   Lee, Ping C ^b   Raff, Hershel ^a,b,c  

^a ST LUKE S MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Endocrinology and Diabetes   (United States)

Author keywords

Glucocorticoid therapy; Hypoxia; Neonate

Indexed keywords

CARDIOLIPIN; CHOLESTEROL ESTER; DEXAMETHASONE; FATTY ACID; LIPID; PHOSPHATIDYLCHOLINE; SURFACTANT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FATTY ACID ANALYSIS; HYPERLIPIDEMIA; LIPID ANALYSIS; LIPID BRAIN LEVEL; LIPID COMPOSITION; LIPID METABOLISM; LUNG; LUNG ARTERIAL HYPOXIA; LUNG FUNCTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BIOLOGICAL MARKERS; BRAIN; DEXAMETHASONE; FATTY ACIDS; LIPID METABOLISM; LUNG; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; SERUM;

EID: 14144253472     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01029.2004     Document Type: Article

References (55)

1. American College of Obstetrics and Gynecology Practice Bulletin. Management of preterm labor. Int J Gynecol Obstet 82: 127-135, 2003.
2. Amin SB, Sinkin RA, McDermott MP, and Kendig JW. Lipid intolerance in neonates receiving dexamethasone for bronchopulmonary dysplasia. Arch Pediatr Adolesc Med 153: 795-800, 1999.
3. Banks BA, Stouffer N, Cnaan A, Ning Y, Merrill JD, Ballard RA, and Ballard PL. North American Thyrotropin-Releasing Hormone Trial Collaborators. Association of plasma cortisol and chronic lung, disease in preterm infants. Pediatrics 107: 494-498, 2001.
4. Baud O. Postnatal steroid treatment and brain development. Arch Dis Child Fetal Neonatal Ed 89: F96-F100, 2004.
5. Bensky AS, Kothadia JM, and Covitz W. Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics 97: 818-821, 1996.
6. Bernhard W, Hoffmann S, Dobrowsky H, Rau GA, Kamlage A, Kappler M, Haitsma JJ, Freihorst J, von der Hardt H, and Poets CF. Phosphatidylcholine molecular species in lung surfactant: composition in relation to respiratory rate and lung development. Am J Respir Cell Mol Biol 25: 725-731, 2001.
7. Bolt RJ, van Weissenbruch MM, Lafeber HN, and Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 32: 76-91, 2001.
8. Bruder ED, Lee PC, and Raff H. Metabolomic analysis of adrenal lipids during hypoxia in the neonatal rat: implications in steroidogenesis. Am J Physiol Endocrinol Metab 286: E697-E703, 2004.
9. Bruder ED, Lee PC, and Raff H. Metabolic consequences of hypoxia from birth and dexamethasone treatment in the neonatal rat: comprehensive hepatic lipid and fatty acid profiling. Endocrinology 145: 5364-5372, 2004.
10. Bruder ED, Lee PC, and Raff H. Lipid and fatty acid profiles in the brain, liver, and stomach contents of neonatal rats: effects of hypoxia. Am J Physiol Endocrinol Metab 288: E314-E320, 2005.
11. Burri PH. The postnatal growth of the rat lung. 3. Morphology. Anat Rec 180: 77-98, 1974.
12. Chiodi H and Whitmore S. Lipid metabolism in suckling rat with fatty liver induced by hypoxia. Experientia 30: 463-465, 1974.
13. Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 88: 421-427, 1991.
14. De Vries WB, Van der Leij FR, Bakker JM, Kamphuis PJGH, Van Oosterhout MFM, Schipper MEI, Smid GB, Bartelds B, and Van Bel F. Alterations in adult rat heart after neonatal dexamethasone therapy. Pediatr Res 52: 900-906, 2002.
15. Flagel SB, Vazquez DM, Watson SJ, and Neal CR. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. Am J Physiol Regul Integr Comp Physiol 282: R55-R63, 2002.
16. Folch J, Lees M, and Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
17. Ford LR, Willi SM, Hollis BW, and Wright NM. Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy. J Pediatr 131: 722-726, 1997.
18. Frankel L and Stevenson DK. Metabolic emergencies of the newborn: hypoxemia and hypoglycemia. Compr Ther 13: 14-19, 1987.
19. Friedman AH and Fahey JT. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease. Semin Perinatol 17: 106-121, 1993.
20. Grongnet JF. Metabolic consequences of induced hypoxia in newborn lambs. Ann Rech Vet 15: 17-28, 1984.
21. Guthmann F, Harrach-Ruprecht B, Looman AC, Stevens PA, Robenek H, and Rustow B. Interaction of lipoproteins with type II pneumocytes in vitro: morphological studies, uptake kinetics and secretion rate of cholesterol. Eur J Cell Biol 74: 197-207, 1997.
22. Haines TH and Dencher NA. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett 528: 35-39, 2002.
23. Halliday HL. Postnatal steroids and chronic lung disease in the newborn. Paediatr Respir Rev 5: S245-S248, 2004.
24. He J, Varma A, Weissfeld LA, and Devaskar SU. Postnatal glucocorticoid exposure alters the adult phenotype. Am J Physiol Regul Integr Comp Physiol 287: R198-R208, 2004.
25. Huysman MWA, Hokken-Koelega ACS, De Ridder MAJ, and Sauer PJJ. Adrenal function in sick very preterm infants. Pediatr Res 48: 629-633, 2000.
26. Iverson SL and Orrenius S. The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. Arch Biochem Biophys 423: 37-46, 2004.
27. Jensen CL and Heird WC. Lipids with an emphasis on long-chain polyunsaturated fatty acids. Clin Perinatol 29: 261-281, 2002.
28. Koshkin V and Greenberg ML. Oxidative phosphorylation in cardiolipin-lacking yeast mitochondria. Biochem J 347: 687-691, 2000.
29. Lee PC, Jelinek B, Struve M, Bruder ED, and Raff H. Effect of neonatal hypoxia on the development of hepatic lipase in the rat. Am J Physiol Regul Integr Comp Physiol 279: R1341-R1347, 2000.
30. LeFlore JL, Salhab WA, Broyles RS, and Engle WD. Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates. Pediatrics 110: 275-279, 2002.
31. Low JA, Froese AB, Galbraith RS, Smith JT, Sauerberi EE, and Derrick EJ. The association between preterm newborn hypotension and hypoxemia and outcome during the first year. Acta Paediatr 82: 433-437, 1993.
32. Marszalek JR, Kitidis C, Dararutana A, and Lodish HF. Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite growth. J Biol Chem 279: 23882-23891, 2004.
33. McEvoy C, Bowling S, Williamson K, McGaw P, and Durand M. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia. Pediatr Pulmonol 38: 55-63, 2004.
34. Momma K, Nakanishi T, and Imamura S. Inhibition of in vivo constriction of fetal ductus arteriosus by endothelin receptor blockade in rats. Pediatr Res 53: 479-485, 2003
35. Mortola JP. How newborn mammals cope with hypoxia. Respir Physiol 116: 95-103, 1999.
36. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, Jolesz FA, and Volpe JJ. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 107: 217-221, 2001.
37. Neal CR, Weidemann G, Kabbaj M, and Vazquez DM. Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. Am J Physiol Regul Integr Comp Physiol 287: R375-R385, 2004.
38. Plonne D, Schulze HP, Kahlert U, Meltke K, Seidolt H, Bennett AJ, Cartwright IJ, Higgins JA, Till U, and Dargel R. Postnatal development of hepatocellular apolipoprotein B assembly and secretion in the rat. J Lipid Res 42: 1865-1878. 2001.
39. Raff H. Neonatal dexamethasone therapy: short and long-term consequences. Trends Endocrinol Metab 15: 351-352, 2004.
40. Raff H and Chadwick CJ. Aldosterone responses to ACTH during hypoxia in conscious rats. Clin Exp Pharmacol Physiol 13:827-830, 1986.
41. Raff H, Jankowski BM, Bruder ED, Engeland WC, and Oaks MK. The effect of hypoxia from birth on the regulation of aldosterone in the 7-day-old rat plasma hormones, steroidogenesis in vitro and steroidogenic enzyme mRNA. Endocrinology 140; 3147-3153, 1999.
42. Raff H, Sandri RB, and Segerson TP. Renin, ACTH, and adrenocortical function during hypoxia and hemorrhage in conscious rats. Am J Physiol Regul Integr Comp Physiol 250: R240-R244, 1986.
43. Rooney SA, Smart DA, Weinhold PA, and Feldman DA. Dexamethasone increases the activity but not the amount of choline-phosphate cytidylyltransferase in fetal rat lung. Biochim Biophys Acta 1044: 385-389, 1990.
44. Shelley SA, Pagica JE, and Balis JU. Lung surfactant phospholipids in different animal species. Lipids 19: 857-862, 1984.
45. Shimizu H, Miyamura K, and Kuroki Y. Appearance of surfactant proteins, SP-A and SP-B, in developing rat lung and the effects of in vivo dexamethasone treatment. Biochim Biophys Acta 1081: 53-60, 1991.
46. Sinkin RA, Dweck HS, Horgan MJ, Gallaher KJ, Cox C, Maniscalco WM, Chess PR, D'Angio CT, Guillet R, Kendig JW, Ryan RM, and Phelps DL. Early dexamethasone-attempting to prevent chronic lung disease. Pediatrics 105: 542-548, 2000.
47. Sullivan LC and Orgeig S. Dexamethasone and epinephrine stimulate surfactant secretion in type II cells of embryonic chickens. Am J Physiol Regul Integr Comp Physiol 281: R770-R777, 2001.
48. Takamoto DY, Lipp MM, von Nahmen A, Lee KYC, Waring AJ, and Zasadzinksi JA. Interaction of lung surfactant proteins with anionic phospholipids. Biophys J 81: 153-169, 2001.
49. Thomas T and Marshall JM. A study on rats of the effects of chronic hypoxia from birth on respiratory and cardiovascular responses evoked by acute hypoxia. J Physiol 487: 513-525, 1995.
50. Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 108: 741-748, 2001.
51. Watkins SM, Lin TY, Davis RM, Ching JR, DePeters GM, Halpern GM, Walzern RI, and German JB. Unique phospholipid metabolism in mouse heart in response to dietary docosahexaenoic or α-linolenic acids. Lipids 36: 247-254, 2001.
52. Watkins SM, Reifsnyder PR, Pan H, German JB, and Leiter EH. Lipid metabolome-wide effects of the PPAR-gamma agonist rosiglitazone. J Lipid Res 43: 1809-1817, 2002.
53. Watterberg KL, Scott SM, Backstrom C, Gifford KL, and Cook KL. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 105: 320-324, 2000.
54. Wolfe RR, Martini WZ, Irtun O, Hawkins HK, and Barrow RE. Dietary fat composition alters pulmonary function in pigs. Nutrition 18: 647-653, 2002.
55. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, and Tsai CH. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350: 1304-1313, 2004.